Holen Sie sich die Stockscreener-App
26.44
1.30%
0.34
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Cantor Fitzgerald Raises Pfizer (PFE) PT to $27 Amid Shifting Obesity Data Focus - Finviz
Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts - Yahoo Finance
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? - The Motley Fool
‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology - Yahoo Finance
Pfizer: Buyer Beware, The Risk Outweighs The Reward (NYSE:PFE) - Seeking Alpha
Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings? - Finviz
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
Pfizer Inc (NYSE:PFE) Emerges as a High-Quality Technical Breakout Candidate - Chartmill
Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19 - Yahoo Finance
PFIZER Stock Holds Near $25.86 as Forecast Targets $36.16 Upside - Analytics Insight
Ahead of Pfizer (PFE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Price Over Earnings Overview: Pfizer - Benzinga
Pfizer: A High-Yield Pharma At A Turning Point (NYSE:PFE) - Seeking Alpha
Can't compromise nation's sovereignty: Supreme Court to settle law on Letters Rogatory in Pfizer-Softgel case - Bar and Bench
'Will US Authorities Cooperate If Indians Seek Information?' : Supreme Court Asks Pfizer On Plea To... - Live Law
Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline - Finviz
Is There Now An Opportunity In Pfizer (PFE) After Recent Pandemic Demand Reset? - simplywall.st
Pfizer's Revenue Rebound Potential is Significant - Intellectia AI
TrumpRx Launch: Pfizer (PFE) and Other Pharma Giants Join New Pl - GuruFocus
Wolfe Research Adjusts Price Target on Pfizer to $25 From $24, Maintains Underperform Rating - marketscreener.com
Has Novavax cracked the code for survival in the vaccine arena? - Pharma Voice
Pfizer Reshapes Portfolio As ViiV Exit Meets White House Pricing Deal - Yahoo Finance
Biosimilars Market Huge Growth in Future Scope 2026-2033 | Amgen Inc., Pfizer Inc., Samsung Bioepis Co., Ltd. - openPR.com
CMS Names Pfizer, Eli Lilly, and AbbVie Drugs for Third Medicare Price Talks - TipRanks
Pfizer Reshapes Pipeline With Novavax Deal And ViiV Exit - simplywall.st
Pfizer (PFE) Among Firms Facing Medicare Drug Price Negotiations - GuruFocus
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
US names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks - marketscreener.com
US names HIV, arthritis drugs for next Medicare price talks - Reuters
What are Wall Street analysts' target price for Pfizer stock? - MSN
US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks - Yahoo! Finance Canada
Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey - Pfizer
The Analyst Verdict: Pfizer In The Eyes Of 7 Experts - Benzinga
Pfizer (PFE) Analyst Rating Update: Cantor Fitzgerald Raises Pri - GuruFocus
Why Is Pfizer Stock Rising Tuesday? - Benzinga
Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug - Benzinga
Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline - Finviz
CMA Seeks To Appeal Re-Do Of £70M Pfizer, Flynn Drug Fines - Law360
118,500 Shares in Pfizer Inc. $PFE Acquired by Y Intercept Hong Kong Ltd - MarketBeat
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively - Yahoo Finance
Macrolide Antibiotics Market to Witness Stunning Growth - openPR.com
Pfizer vs. Merck Stock And JNJ - Forbes
With 66% Ownership of the Shares, Pfizer Inc. (NYSE:PFE) Is Heavily Dominated by Institutional Owners - 富途牛牛
Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance (NYSE:PFE) - Seeking Alpha
Pfizer’s CEO on leading after a moonshot—and making deals with Trump - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sundrug Co (OtherSDGCF) - The Globe and Mail
What Are Wall Street Analysts' Target Price for Pfizer Stock? - Barchart.com
Pfizer CEO Albert Bourla stared down the COVID-19 pandemic. Now he has his eyes set on cancer - Fortune
Pfizer (PFE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Pfizer Inc. - Britannica
Pfizer Recasts Infectious Disease Focus With ViiV Exit And Matrix M Access - simplywall.st
Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch - TipRanks
Recent Report Shows That Rep. French Hill Sold Up to $365K Worth of Pfizer Stock - Benzinga
Pfizer Stock Forecast 2026–2030 | Future Outlook - Capital.com
Parthenon LLC Has $1.27 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Corticosteroids Market Report 2026 - GlobeNewswire Inc.
Callahan Advisors LLC Acquires 43,454 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Avantax Planning Partners Inc. - MarketBeat
Pfizer to exit ViiV Healthcare as GSK and Shionogi reshape ownership - MSN
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership - Yahoo Finance
Quilter Plc Cuts Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Sector Gamma AS Increases Stake in Pfizer Inc. $PFE - MarketBeat
UniSuper Management Pty Ltd Increases Position in Pfizer Inc. $PFE - MarketBeat
1.72%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):